🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

165 results for “Sunshine” Clear

  1. [14C] Yiqibuvir

    Sunshine Biopharma

    Healthy Male Subjects

    phase 1 small molecule completed

    1 trial

  2. [14C]- Rongliflozin

    Sunshine Biopharma

    Healthy Adult Male Volunteers

    phase 1 small molecule completed

    1 trial

  3. [14C]-HEC585

    Sunshine Biopharma

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  4. [14C]-Larotinib

    Sunshine Biopharma

    Healthy Adult Male Volunteers

    phase 1 small molecule completed

    1 trial

  5. [14C]Clifutinib

    Sunshine Biopharma

    Healthy Adult Male

    phase 1 small molecule completed

    1 trial

  6. [14C]SSS17

    Sunshine Biopharma

    Healthy Subjects (HS)

    phase 1 small molecule active

    1 trial

  7. new formulations of 611

    Sunshine Biopharma

    Atopic Dermatitis

    phase 1 small molecule active

    1 trial

  8. pyroglutamate rongliflozin capsules

    Sunshine Biopharma

    Type 2 Diabetes

    phase 1 small molecule completed

    1 trial

  9. pyroglutamate rongliflozin capsules

    Sunshine Biopharma

    Diabetes Mellitus, Type 2

    phase 1 small molecule completed

    1 trial

  10. recombinant human thrombopoietin injection

    Sunshine Biopharma

    Liver Disease Chronic

    phase 1 small molecule active

    1 trial

  11. yimitasvir

    Sunshine Biopharma

    Chronic Hepatitis c

    phase 1 small molecule completed

    1 trial

  12. Ceftolozane/tazobactam

    Sunshine Biopharma

    Bronchiectasis

    approved small molecule active

    1 trial

  13. EPIAO®

    Sunshine Biopharma

    Renal Anaemia

    approved small molecule terminated

    1 trial

  14. Sulforaphane

    Sunshine Biopharma

    HIV Infections

    approved small molecule active

    1 trial

  15. TPO

    Sunshine Biopharma

    ITP

    approved small molecule completed

    1 trial

  16. rhTPO

    Sunshine Biopharma

    Previously Treated Primary Immune Thrombocytopenia

    approved small molecule completed

    1 trial

  17. Experimental

    Sunshine Biopharma

    Cognitive Health

    other completed

    1 trial

  18. MINGO

    Sunshine Biopharma

    X-Linked Dystonia Parkinsonism

    other completed

    1 trial

  19. PROGRAM

    Sunshine Biopharma

    Obesity

    other completed

    1 trial

  20. Power Line Program

    Sunshine Biopharma

    Metabolic Health

    other completed

    1 trial

  21. Redefine

    Sunshine Biopharma

    Obesity & Overweight

    other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources